Arrow Mark Colorado Holdings LLC Athenex, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$5.71 - $15.85 $127,418 - $353,692	-22,315 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $240,000 - $443,750	-25,000 Reduced 52.84%	22,315 $341,000
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $575,350 - $993,615	47,315 New	47,315 $576,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $19.8 $377,600 - $792,000	-40,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.11 - $13.49 $222,200 - $269,800	20,000 Added 100.0%	40,000 $490,000
Q4 2018 Feb 14, 2019	BUY	$10.24 - $15.49 $204,800 - $309,800	20,000 New	20,000 $254,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.